The forecasted consumption of medications for Peptic Ulcer and Gastro-Oesophageal Reflux Diseases in Canada shows a steady increase from 2024 to 2028, with defined daily dosages per thousand people per day rising from 84.0 to 95.2. Comparing each year's data, the year-on-year percentage increase is consistent, indicating a smooth trend. With 2024 as the baseline, the average compound annual growth rate over the five-year period highlights a steady increase in medication use.

Future trends to watch for include advancements in treatment options that could impact usage patterns, potential shifts in healthcare policies that might influence prescription rates, and the evolving demographic landscape affecting demand for such medications.